Ironwood Pharmaceuticals | IRWD - 员工 总数



金融业
股票价格
USD
资产
USD 396.06M
现金及等价物
USD 140.41M
销售成本
USD 29.83M
流动资产
USD 273.84M
流动负债
USD 242.5M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD -0.01
股本和储备
USD -264.16M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 731M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 47.71M
销售和管理费用
USD 33.33M
贸易债权人
USD 1.61M
应收帐款人
USD 81.89M


员工 更改 日
Acadia Pharmaceuticals 653 56 2024-12
Agios Pharmaceuticals 486 103 2024-12
Akebia Therapeutics 167 37 2023-12
Almirall 1.9K 58 2023-12
Alnylam Pharmaceuticals 2.23K 130 2024-12
Amarin 275 90 2023-12
Ardelyx 395 128 2024-12
Astellas Pharma 13.64K 1.11K 2025-12
AstraZeneca USD 89.9K 6.4K 2023-12
Charles River Laboratories 18.6K 1.4K 2024-12
Coherus Biosciences 306 53 2023-12
Emergent BioSolutions 1.6K 900 2023-12
Esperion Therapeutics 240 41 2023-12
Halozyme Therapeutics 350 23 2024-12
Incyte 2.62K 93 2024-12
Ironwood Pharmaceuticals 267 48 2023-12
Karyopharm Therapeutics 325 60 2023-12
Lexicon Pharmaceuticals 285 150 2023-12
MacroGenics 339 18 2023-12
Moderna 5.8K 200 2024-12
Myriad Genetics 2.7K 0 2024-12
Pacira 790 79 2024-12
PTC Therapeutics 939 49 2024-12
Puma Biotechnology 185 7 2023-12
Sarepta Therapeutics 1.37K 58 2024-12
Takeda 47.46K 1.83K 2025-12
Ultragenyx Pharmaceutical 1.29K 18 2024-12
Vanda Pharmaceuticals 203 87 2023-12